Skip to Main Content

Researchers on Wednesday unveiled the chemical structure of what could become the first in a new class of drugs to treat malaria.

It’s an early but promising step in the effort to find new ways to treat the mosquito-borne blood disease. Two of the common parasites behind the disease are increasingly developing a resistance to the antibiotics typically prescribed as treatment. Finding drugs that work in completely new ways will be critical to meeting a global goal of reducing the number of people infected with malaria by 90 percent by 2030.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.